News Releases

12/04/19	Millendo Therapeutics Announces Pricing of Public Offering of Common Stock
12/04/19	Millendo Therapeutics Announces Proposed Public Offering of Common Stock
11/13/19	Millendo Therapeutics Reports Third Quarter 2019 Operating and Financial Results
11/13/19	Millendo Therapeutics Completes Patient Recruitment for Pivotal Study of Livoletide in Prader-Willi Syndrome
11/11/19	Millendo Therapeutics to Present at the Stifel 2019 Healthcare Conference
11/07/19	Millendo Therapeutics to Host Prader-Willi Syndrome (PWS) Breakfast Symposium on Thursday, November 14, 2019
09/26/19	Millendo Therapeutics to Present at Prader-Willi Syndrome Conferences
08/29/19	Millendo Therapeutics to Participate in September Investor Conferences
08/20/19	Millendo Therapeutics Appoints Tamara Joseph as General Counsel and Ryan Zeidan as Chief Development Officer
08/12/19	Millendo Therapeutics Reports Second Quarter 2019 Operating and Financial Results

News Releases

Shareholder Tools